China Resources Pharmaceutical Group's (HKG:3320) subsidiary Dong-E-E-Jiao expects to record a profit attributable to its shareholders between 1.10 billion yuan and 1.18 billion yuan for the nine months ended Sept. 30, 40% to 50% higher than 783.7 million yuan logged for the same period last year, a Wednesday filing with the Hong Kong Exchange said.
The company attributed the increase in profit to Dong-E-E-Jiao's consumer-centered approach, integrating marketing with digital placement and adoption of a "dual-wheel drive" growth model.
The pharmaceutical and healthcare products company's shares closed nearly 4% lower on Wednesday.
Price (HKD): $5.93, Change: $-0.22, Percent Change: -3.58%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。